JP Equity Research Note - July 2022 Categories: Investor Presentations 2022, News & Announcements 2022, Research Notes 2022By PharmAustJuly 22, 2022Related postsPharmAust opens door to billion-dollar markets, following MPL trial successesAugust 1, 2022Broker JP Equity says PharmAust has multiple avenues to $US 1 billion+ successJuly 27, 2022Appendix 4C and Quarterly UpdateJuly 21, 2022PharmAust subsidiary Epichem lands pilot deal with Shell Australia to convert waste plastic to productsJuly 13, 2022July 1, Top 20 ShareholdersJuly 1, 2022Science Week Conference PresentationJune 24, 2022
PharmAust subsidiary Epichem lands pilot deal with Shell Australia to convert waste plastic to productsJuly 13, 2022